ANDROGEL (testosterone) by Besins Healthcare is androgen receptor agonists [moa]. First approved in 2011.
Drug data last refreshed 5h ago · AI intelligence enriched Yesterday
ANDROGEL is a transdermal gel formulation of testosterone, an androgen receptor agonist used to treat testosterone deficiency in adult males. It works by binding to androgen receptors to restore physiological testosterone levels. The product is indicated for hormone replacement therapy in hypogonadal men.
With LOE imminent (October 2026) and declining Part D claims, the brand team is contracting and shifting focus toward lifecycle management and transition planning rather than growth initiatives.
Androgen Receptor Agonists
Androgen
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
Testosterone Therapy With or Without Finasteride After Spinal Cord Injury: TRT-SCI Trial
Testosterone Treatment for Erectile Dysfunction and Multiple Sclerosis
Supraphysiologic Testosterone Priming Induces Darolutamide Extended Response
Testosterone Deficiency and Endothelial Dysfunction After Spinal Cord Injury
52 Week Study + 24-Month Long-Term Extension of Safety, PK, & Efficacy of XYOSTED® for Testosterone Replacement in Male Adolescents With Hypogonadism
Worked on ANDROGEL at Besins Healthcare? Share your interview experience or compensation data (+7 days Pro)
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.
Upgrade to Pro to access patent cliff timelines and LOE dates and other premium pharma intelligence.
Upgrade to Pro — $25/moUpgrade to Pro to access Medicare Part D spending data and other premium pharma intelligence.
Upgrade to Pro — $25/moUpgrade to Pro to access CMS Part B ASP pricing data and other premium pharma intelligence.
Upgrade to Pro — $25/moBesins Healthcare is hiring 2 roles related to this product
Patent cliff in less than a year — expect lifecycle management and generic defense hiring
Working on ANDROGEL offers limited career advancement given its LOE-approaching status and minimal linked job openings (2 total). This position is suited for professionals seeking stability in a mature product with established patient populations rather than those pursuing high-growth commercial or clinical career trajectories.
2 open roles linked to this drug